Education
About Us
Working with TipRanks
Follow Us
Amedisys Inc (AMED)
NASDAQ:AMED
AMED Stock Chart & Stats
Day’s Range― - ―
52-Week Range$82.15 - $98.95
Previous CloseN/A
Volume84.60K
Average Volume (3M)348.34K
Market Cap
$3.03B
Enterprise Value$3.47B
Total Cash (Recent Filing)$303.24M
Total Debt (Recent Filing)$460.18M
Price to Earnings (P/E)71.2
Beta0.31
Next Earnings
Apr 23, 2025EPS Estimate
1.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding32,810,290
10 Day Avg. Volume407,037
30 Day Avg. Volume348,337
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)N/A
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)12.60
P/FCF Ratio10.40
Enterprise Value/Market Cap1.15
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.41
Enterprise Value/Ebitda21.97
Forecast
1Y Price Target
$100.80Price Target Upside8.69% Upside
Rating ConsensusHold
Number of Analyst Covering7
---
Amedisys News
PremiumCompany Announcements
Amedisys Reports 2024 Financial Results Amid Merger Plans
PremiumCompany Announcements
Amedisys Reports Q4 2024 Financial Results Amid Merger Plans
---
Bulls Say, Bears Say
Bulls Say
Acquisition DevelopmentsCertain closing conditions relating to government approvals are no longer conditions to the consummation of the merger, indicating a smoother path to completion.
Financial StabilityNet leverage was reduced to 1.0x TTM EBITDA, showing improved financial stability.
Revenue PerformanceHome health revenue of $377.0 million beat our $373.3 million estimate as average revenue per episode of $3,030 exceeded our $2,997 estimate and same-store non-Medicare revenue increased 19%.
Bears Say
Cost And ProfitabilityThe EBITDA miss was driven by an elevated cost of service revenue ratio.
Earnings PerformanceThe 4Q24 results came in below both consensus estimates and the analyst's model.
Future EstimatesThe expectation for continued pressure on Medicare fee-for-service volume growth slightly lowers the 2025 estimates for Amedisys.
---
Ownership Overview
2.34% Insiders
20.91% Mutual Funds
38.96% Other Institutional Investors
11.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AMED FAQ
What was Amedisys Inc’s price range in the past 12 months?
Amedisys Inc lowest stock price was $82.15 and its highest was $98.95 in the past 12 months.
What is Amedisys Inc’s market cap?
Amedisys Inc’s market cap is $3.03B.
When is Amedisys Inc’s upcoming earnings report date?
Amedisys Inc’s upcoming earnings report date is Apr 23, 2025 which is in 28 days.
How were Amedisys Inc’s earnings last quarter?
Amedisys Inc released its earnings results on Feb 26, 2025. The company reported $0.96 earnings per share for the quarter, missing the consensus estimate of $1.048 by -$0.088.
Is Amedisys Inc overvalued?
According to Wall Street analysts Amedisys Inc’s price is currently Undervalued.
Does Amedisys Inc pay dividends?
Amedisys Inc does not currently pay dividends.
What is Amedisys Inc’s EPS estimate?
Amedisys Inc’s EPS estimate is 1.11.
How many shares outstanding does Amedisys Inc have?
Amedisys Inc has 32,810,290 shares outstanding.
What happened to Amedisys Inc’s price movement after its last earnings report?
Amedisys Inc reported an EPS of $0.96 in its last earnings report, missing expectations of $1.048. Following the earnings report the stock price went up 0.12%.
Which hedge fund is a major shareholder of Amedisys Inc?
Currently, no hedge funds are holding shares in AMED
---
Amedisys Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$100.80 (8.69% Upside)
$100.80 (8.69% Upside)
Blogger Sentiment
Neutral
AMED Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 153.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $187.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 6.1%
Last 30 Days ▼ 6.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.64%
12-Months-Change
Fundamentals
Return on Equity
3.93%
Trailing 12-Months
Asset Growth
3.81%
Trailing 12-Months
Company Description
Amedisys Inc
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
---
AMED Stock 12 Month Forecast
Average Price Target
$100.80
▲(8.69% Upside)
Technical Analysis
AMN Healthcare Services
―
Chemed
―
Healthcare Services
―
Encompass Health
―
The Ensign Group
―
Best Analysts Covering AMED
1 Year
Unknown AnalystRBC Capital
Not Ranked
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 3 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
---